Texas Yale Capital Corp. Novartis Ag Transaction History
Texas Yale Capital Corp.
- $2.47 Billion
- Q4 2024
A detailed history of Texas Yale Capital Corp. transactions in Novartis Ag stock. As of the latest transaction made, Texas Yale Capital Corp. holds 3,952 shares of NVS stock, worth $430,451. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,952
Previous 3,662
7.92%
Holding current value
$430,451
Previous $421,000
8.79%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,476Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$891 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$748 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$607 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $234B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...